Answers are grounded in this paper and cite their sources.
Our study results reduce support for pre-enrollment antimalaria treatment as a sole explanation for the observed lower falciparum prevalence in eBL cases and open a space to consider alternative immunology-based hypotheses.
No takes yet. Share an insight, caveat, or question.
Peprah et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: